Dr. Reddy's Labs Files Routine 6-K Disclosure
Ticker: RDY · Form: 6-K · Filed: Sep 2, 2025 · CIK: 1135951
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
DRL filed a 6-K, just a routine check-in, no big news.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 2, 2025, to report its status as a foreign private issuer. The company, headquartered in Hyderabad, India, is required to file annual reports under Form 20-F. This filing does not contain specific financial figures or operational updates but serves as a routine disclosure.
Why It Matters
This filing indicates Dr. Reddy's Laboratories is adhering to its reporting obligations as a foreign private issuer with the SEC, which is standard for international companies trading on US exchanges.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain material non-public information that would typically impact stock price.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Filer of the 6-K report
- Hyderabad, India (location) — Company headquarters
- 0001575872-25-000555 (filing_id) — Accession number for the filing
- 20250902 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer publishes, is required to publish, or is required to file in the country where it is incorporated or has its principal place of business.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is September 2, 2025.
Where is Dr. Reddy's Laboratories Limited headquartered?
Dr. Reddy's Laboratories Limited is headquartered at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories indicates it files annual reports under cover of Form 20-F.
Does this filing contain specific financial results or operational updates?
No, this filing is a routine report of foreign private issuer status and does not contain specific financial results or operational updates.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-09-02 07:53:39
Filing Documents
- rdy0798_6k.htm (6-K) — 49KB
- rdy0798_ex99-1.htm (EX-99.1) — 38KB
- rdy0798_ex99-1img01.jpg (GRAPHIC) — 10KB
- rdy0798_ex99-1img02.jpg (GRAPHIC) — 7KB
- 0001575872-25-000555.txt ( ) — 111KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: September 2, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3